Skip to main content

Advertisement

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Videos

Tumor Treating Fields Associated With Significant Survival Benefit in Newly Diagnosed Glioblastoma


Matthew Ballo, MD, West Cancer Center, Germantown, Tennessee, discusses results from a meta-analysis of comparative studies showing a significant survival benefit with tumor treating fields therapy added to standard radiochemotherapy for patients with newly diagnosed glioblastoma.

Dr Ballo presented these findings at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting.


Source:

Ballo MT, Conlon P, Lavy-Shahaf G, et al. Real-world experience with tumor treating fields (TTFields) in newly diagnosed glioblastoma: A survival meta-analysis with systematic review. Presented at the ASCO Annual Meeting; June 2-6, 2023; Chicago, Illinois. Abstract 2059

Advertisement

Advertisement

Advertisement

Advertisement